Thrombotic thrombocytopenic purpura (TTP), first described by Moschcowitz in 1924,[1][1] has long been known as a generally fatal acute disease occurring in previously healthy subjects[2][2]. Despite its rarity, over the past eight decades it has attracted the interest of many researchers and
No takes yet. Share an insight, caveat, or question.
Lämmle et al. (2008) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: